Skip to main content
Fig. 3 | The Journal of Headache and Pain

Fig. 3

From: The efficacy and safety of zavegepant nasal inhalation versus oral calcitonin-gene related peptide receptor antagonists in the acute treatment of migraine: a systematic review and network meta-analysis of the literature

Fig. 3

Network structures of the outcomes. (a-b) Primary outcome: (a) pain freedom at 2 hours. (b) freedom from the most bothersome symptom (MBS) at 2 hours. (c-i) Secondary outcome: (c) pain relief at 2 hours. (d) sustained pain freedom from 2 to 24 hours. (e) sustained pain freedom from 2 to 48 hours. (f) sustained pain relief from 2 to 24 hours. (g) sustained pain relief from 2 to 48 hours. (h) phonophobia freedom at 2 hours. (i) photophobia freedom at 2 hours. The lines between the nodes indicate direct comparisons in different trials. The coarseness of the lines is proportional to the number of trials linked in the network

Back to article page

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us